At close: December 20 at 8:08:20 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-362.1170
--
-1,543.8710
954.1700
1,315.5780
Investing Cash Flow
-231.2260
--
-3,964.2740
-1,597.3590
-2,569.9390
Financing Cash Flow
2,412.5140
--
1,114.2390
3,878.7200
1,911.0050
End Cash Position
3,808.6330
--
5,791.5620
10,185.4680
6,949.9370
Income Tax Paid Supplemental Data
5.1660
--
4.9230
5.1100
4.5810
Interest Paid Supplemental Data
545.2790
--
338.5160
308.6820
481.4080
Capital Expenditure
-350.8530
--
-3,975.2740
-2,608.6490
-4,072.5390
Issuance of Capital Stock
--
--
--
4,233.0260
--
Issuance of Debt
--
--
2,000.0000
400.0000
11,537.7000
Repayment of Debt
-1,450.8650
--
-897.1250
-768.2710
-9,573.5680
Free Cash Flow
-712.9700
--
-5,519.1450
-1,654.4790
-2,756.9610
12/31/2020 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XI3.F Bioceltix S.A.
16.46
+0.98%
CY71.F Anixa Biosciences, Inc.
2.5600
+6.67%
174900.KQ AbClon Inc.
13,760.00
-1.92%
CRTHF CARsgen Therapeutics Holdings Limited
0.7465
0.00%
6JH.BE IN8bio Inc
0.2340
-2.50%
6JH.SG IN8bio Inc
0.2280
-10.24%
IMR.SG AC Immune SA
2.5700
-2.84%
6JH.MU IN8bio, Inc.
0.2360
-10.61%
IMR.F AC Immune SA
2.6750
+2.29%
S09.F Sutro Biopharma, Inc.
1.7000
-9.09%